José Miguel Neves
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
José Miguel Neves has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Alexandre João
Dermatology and Venereology Department Centro Hospitalar Universitário de Lisboa Central, E.P.E Lisbon Portugal
4 shared publications- André Lencastre
Dermatology Department, Hospital da Luz, Lisbon, Portugal
3 shared publications Cândida Fernandes
Dermatology and Venereology Department Centro Hospitalar Universitário de Lisboa Central Lisbon Portugal
3 shared publications- Ana Luísa João
Dermatology Department, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal
2 shared publications C. Fernandes
Dermatology Department Hospital Santo António dos Capuchos Centro Hospitalar Universitário de Lisboa Central Lisbon Portugal
2 shared publications- Clara Valente
Dermatology and Venereology Department, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal
2 shared publications
Latest Publications
- Open Access
- 2 February 2026
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 39 (2) , 163-164
Vedolizumab-Induced Photosensitivity: An Underreported Phenomenon?
- 2 February 2026
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 39 (2) , 163-164
Open AccessVedolizumab-Induced Photosensitivity: An Underreported Phenomenon?
- 29 May 2024
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 39 (1) , e98-e99
Beyond genital screening: The role of extragenital testing for Chlamydia trachomatis in women
- 29 May 2024
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 39 (1) , e98-e99
Beyond genital screening: The role of extragenital testing for Chlamydia trachomatis in women
- 22 December 2023
- Published by BMJ in Sexually Transmitted Infections
- Vol. 100 (2) , 120
Mpox after vaccination: a case series
- 22 December 2023
- Published by BMJ in Sexually Transmitted Infections
- Vol. 100 (2) , 120
Mpox after vaccination: a case series
- 4 November 2022
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (2) , E264-E265
Outbreak of monkeypox in an STD clinic in Lisbon
- 4 November 2022
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (2) , E264-E265
Outbreak of monkeypox in an STD clinic in Lisbon
- Open Access
- 1 November 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 97 (6) , 816-819
Tratamento da hidradenite supurativa com adalimumabe – experiência da prática diária em centro terciário de Lisboa, Portugal
- 1 November 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 97 (6) , 816-819
Open AccessTratamento da hidradenite supurativa com adalimumabe – experiência da prática diária em centro terciário de Lisboa, Portugal
- Open Access
- 10 September 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 97 (6) , 816-819
Treating hidradenitis suppurativa patients with adalimumab: a real-life experience of a tertiary care center in Lisboa, Portugal
- 10 September 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 97 (6) , 816-819
Open AccessTreating hidradenitis suppurativa patients with adalimumab: a real-life experience of a tertiary care center in Lisboa, Portugal
- 25 April 2021
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 35 (8) , 1712-1716
Lymphogranuloma venereum: a retrospective analysis of an emerging sexually transmitted disease in a Lisbon Tertiary Center
Background: Lymphogranuloma venereum (LGV) is a sexual transmitted infection (STI), currently endemic within the population of men who have sex with men (MSM) of Western Countries. L2B variant has been reported as the predominant strain in the current LGV epidemics, although a shift towards L2‐434 has been observed in some European countries.Objectives: To evaluate and characterize the population with LGV infection diagnosed in Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.Methods: A retrospective analysis of all LGV diagnoses between 2016 and 2019 was performed. The diagnosis was established through ompA‐genotyping of samples yielding a positive result to Chlamydia trachomatis (CT). All considered samples were retrieved from the clinician activity, through swabbing and urine analysis and CT infection diagnosis was obtained using real‐time PCR.Results: During the period studied 16 279 CT diagnostics tests were employed, with a striking increase from 2016 (n = 467) to 2019 (n = 9362). A total of 1602 diagnoses of CT were established, from which 168 (10.5%) corresponded to LGV, with both infections showing a rising evolution, between 2016 and 2019, of 2.9 and 2.7 times, respectively. The majority of the LGV strains were genotyped as L2/434 (67.3%; n = 113). LGV predominantly affected MSM and men who have sex with men and women (97.0%; n = 163). Anorectal infection was the most prevalent one (90.5%; n = 152), being proctitis the main clinical presentation (76.2%; n = 128). Absence of symptoms was reported in almost 15% of the cases (n = 24). The presence of concomitant infection with human immunodeficiency virus was dominant (73.2%; n = 123) and the prevalence of one or more STI co‐infections was about 60.1% (n = 99).Conclusions: An increasing evolution of CT and LGV testing and diagnosing was observable throughout the studied period. Characteristics of the population are similar with those described within LGV epidemics. In accordance with recent European studies, predominance towards L2 genotype was identified.
- 25 April 2021
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 35 (8) , 1712-1716
Lymphogranuloma venereum: a retrospective analysis of an emerging sexually transmitted disease in a Lisbon Tertiary Center
Background: Lymphogranuloma venereum (LGV) is a sexual transmitted infection (STI), currently endemic within the population of men who have sex with men (MSM) of Western Countries. L2B variant has been reported as the predominant strain in the current LGV epidemics, although a shift towards L2‐434 has been observed in some European countries.Objectives: To evaluate and characterize the population with LGV infection diagnosed in Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.Methods: A retrospective analysis of all LGV diagnoses between 2016 and 2019 was performed. The diagnosis was established through ompA‐genotyping of samples yielding a positive result to Chlamydia trachomatis (CT). All considered samples were retrieved from the clinician activity, through swabbing and urine analysis and CT infection diagnosis was obtained using real‐time PCR.Results: During the period studied 16 279 CT diagnostics tests were employed, with a striking increase from 2016 (n = 467) to 2019 (n = 9362). A total of 1602 diagnoses of CT were established, from which 168 (10.5%) corresponded to LGV, with both infections showing a rising evolution, between 2016 and 2019, of 2.9 and 2.7 times, respectively. The majority of the LGV strains were genotyped as L2/434 (67.3%; n = 113). LGV predominantly affected MSM and men who have sex with men and women (97.0%; n = 163). Anorectal infection was the most prevalent one (90.5%; n = 152), being proctitis the main clinical presentation (76.2%; n = 128). Absence of symptoms was reported in almost 15% of the cases (n = 24). The presence of concomitant infection with human immunodeficiency virus was dominant (73.2%; n = 123) and the prevalence of one or more STI co‐infections was about 60.1% (n = 99).Conclusions: An increasing evolution of CT and LGV testing and diagnosing was observable throughout the studied period. Characteristics of the population are similar with those described within LGV epidemics. In accordance with recent European studies, predominance towards L2 genotype was identified.
- 1 August 2020
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 45 (6) , 745-746
Nonuraemic cutaneous calciphylaxis: our experience with a challenging disease
Calciphylaxis is a rare and potentially life‐threatening syndrome of vascular calcification and skin necrosis. It usually presents with painful, violaceous patches or plaques, in a livedoid pattern, that progress into nonhealing ulcers with underlying tissue necrosis. Calciphylaxis can be classified as central (when proximal to the knees and elbows) or peripheral. The diagnosis is established by histopathology, picturing calcium deposits within the dermal and subcutaneous vessels.1,2 It is classically diagnosed in the setting of end‐stage renal disease, although non‐uremic calciphylaxis (NUC) has been increasingly reported.
- 1 August 2020
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 45 (6) , 745-746
Nonuraemic cutaneous calciphylaxis: our experience with a challenging disease
Calciphylaxis is a rare and potentially life‐threatening syndrome of vascular calcification and skin necrosis. It usually presents with painful, violaceous patches or plaques, in a livedoid pattern, that progress into nonhealing ulcers with underlying tissue necrosis. Calciphylaxis can be classified as central (when proximal to the knees and elbows) or peripheral. The diagnosis is established by histopathology, picturing calcium deposits within the dermal and subcutaneous vessels.1,2 It is classically diagnosed in the setting of end‐stage renal disease, although non‐uremic calciphylaxis (NUC) has been increasingly reported.
- 24 July 2020
- Published by Wiley in Pediatric Dermatology
- Vol. 37 (4) , e49-e50
Ulcerated papules and nodules in an infant
- 24 July 2020
- Published by Wiley in Pediatric Dermatology
- Vol. 37 (4) , e49-e50
Ulcerated papules and nodules in an infant
- Open Access
- 14 July 2020
- Published by Portuguese Society of Dermatology and Venereology in Journal of the Portuguese Society of Dermatology and Venereology
- Vol. 78 (2) , 107-114
Pediatric Melanoma: Epidemiology, Pathogenesis, Diagnosis and Management
Pediatric melanoma is the most common skin cancer in children. However, it is extremely rare this population, being even rarer in younger than 10 years of age. Its diagnosis is often difficult, due to its rarity and atypical presentations. There are three main subtypes of pediatric melanoma: Spitzoid melanoma, melanoma arising in a congenital melanocytic nevus and conventional melanoma. Congenital melanomas exist and are exceptionally rare, although they do not constitute a different subtype of melanoma. Spitzoid melanoma is the most common subtype affecting children younger than 11 years. Despite presenting with local aggressive features and frequent nodal involvement, it encompasses an excellent prognosis. The risk of malignant transformation of congenital melanocytic nevi varies widely accordingly to the projected adult size, number, and concomitant abnormalities found in the central nervous system. The surveillance and treatment of melanoma arising in a congenital melanocytic nevus is challenging, enclosing poor outcomes. In adolescents, the most common subtype is the conventional (adult-type). Contrary to the adult population, the majority of conventional pediatric melanoma arises from previous nevi but follows the general adult epidemiology and risk factors. Specific guidelines for management of pediatric melanoma do not exist and it is treated similarly to melanoma in the adult.
- 14 July 2020
- Published by Portuguese Society of Dermatology and Venereology in Journal of the Portuguese Society of Dermatology and Venereology
- Vol. 78 (2) , 107-114
Open AccessPediatric Melanoma: Epidemiology, Pathogenesis, Diagnosis and Management
Pediatric melanoma is the most common skin cancer in children. However, it is extremely rare this population, being even rarer in younger than 10 years of age. Its diagnosis is often difficult, due to its rarity and atypical presentations. There are three main subtypes of pediatric melanoma: Spitzoid melanoma, melanoma arising in a congenital melanocytic nevus and conventional melanoma. Congenital melanomas exist and are exceptionally rare, although they do not constitute a different subtype of melanoma. Spitzoid melanoma is the most common subtype affecting children younger than 11 years. Despite presenting with local aggressive features and frequent nodal involvement, it encompasses an excellent prognosis. The risk of malignant transformation of congenital melanocytic nevi varies widely accordingly to the projected adult size, number, and concomitant abnormalities found in the central nervous system. The surveillance and treatment of melanoma arising in a congenital melanocytic nevus is challenging, enclosing poor outcomes. In adolescents, the most common subtype is the conventional (adult-type). Contrary to the adult population, the majority of conventional pediatric melanoma arises from previous nevi but follows the general adult epidemiology and risk factors. Specific guidelines for management of pediatric melanoma do not exist and it is treated similarly to melanoma in the adult.